{
    "clinical_study": {
        "@rank": "77496", 
        "brief_summary": {
            "textblock": "The study examines efficacy of repetitive transcranial magnetic stimulation in treating\n      severely depressed patients who are medicated."
        }, 
        "brief_title": "Transcranial Magnetic Stimulation in Depression", 
        "completion_date": "July 2001", 
        "condition": "Depression", 
        "condition_browse": {
            "mesh_term": [
                "Depression", 
                "Depressive Disorder"
            ]
        }, 
        "detailed_description": {
            "textblock": "Medicated, treatment resistant, depressed patients are randomized to active or sham\n      repetitive transcranial magnetic stimulation (rTMS).  Responding patients go into a six\n      months follow-up period."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "severe treatment-resistant depression"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "July 3, 2001", 
        "id_info": {
            "nct_id": "NCT00018746", 
            "org_study_id": "MHBS-037-98S"
        }, 
        "intervention": {
            "intervention_name": "repetitive transcranial magnetic stimulation", 
            "intervention_type": "Device"
        }, 
        "lastchanged_date": "January 20, 2009", 
        "location": {
            "facility": {
                "address": {
                    "city": "West Haven", 
                    "country": "United States", 
                    "state": "Connecticut", 
                    "zip": "06516"
                }, 
                "name": "VA Connecticut Healthcare System"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Efficacy of Threshold vs. Subthreshold TMS in the Treatment of Depression", 
        "overall_official": [
            {
                "last_name": "Ralph Hoffman"
            }, 
            {
                "last_name": "Dan Oren"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "Phase 1", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00018746"
        }, 
        "source": "Department of Veterans Affairs", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Department of Veterans Affairs", 
                "agency_class": "U.S. Fed"
            }
        }, 
        "start_date": "July 1999", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2004"
    }, 
    "geocoordinates": {
        "VA Connecticut Healthcare System": "41.271 -72.947"
    }
}